JP Patent

JP7322259B2 — 真菌感染の処置のための投薬レジメン

Assigned to シダラ セラピューティクス インコーポレーテッド · Expires 2023-08-07 · 3y expired

What this patent protects

Patent listed against rezafungin-acetate.

Drugs covered by this patent

Patent Metadata

Patent number
JP7322259B2
Jurisdiction
JP
Classification
—
Expires
2023-08-07
Drug substance claim
No
Drug product claim
No
Assignee
シダラ セラピューティクス インコーポレーテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.